Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1650

1.

Class IIa HDAC inhibition enhances ER stress-mediated cell death in multiple myeloma.

Kikuchi S, Suzuki R, Ohguchi H, Yoshida Y, Lu D, Cottini F, Jakubikova J, Bianchi G, Harada T, Gorgun G, Tai YT, Richardson PG, Hideshima T, Anderson KC.

Leukemia. 2015 Mar 24. doi: 10.1038/leu.2015.83. [Epub ahead of print]

PMID:
25801913
2.

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT).

Mohty M, Malard F, Abecassis M, Aerts E, Alaskar AS, Aljurf M, Arat M, Bader P, Baron F, Bazarbachi A, Blaise D, Ciceri F, Corbacioglu S, Dalle JH, Duarte RF, Fukuda T, Huynh A, Masszi T, Michallet M, Nagler A, NiChonghaile M, Pagluica T, Peters C, Petersen FB, Richardson PG, Ruutu T, Savani BN, Wallhult E, Yakoub-Agha I, Carreras E.

Bone Marrow Transplant. 2015 Mar 23. doi: 10.1038/bmt.2015.52. [Epub ahead of print]

PMID:
25798682
3.

Resolving the daratumumab interference with blood compatibility testing.

Chapuy CI, Nicholson RT, Aguad MD, Chapuy B, Laubach JP, Richardson PG, Doshi P, Kaufman RM.

Transfusion. 2015 Mar 12. doi: 10.1111/trf.13069. [Epub ahead of print]

PMID:
25764134
4.

Design, Synthesis, and Evaluation of NO-Donor Containing Carbonic Anhydrase Inhibitors To Lower Intraocular Pressure.

Huang Q, Rui EY, Cobbs M, Dinh DM, Gukasyan HJ, Lafontaine JA, Mehta S, Patterson BD, Rewolinski DA, Richardson PF, Edwards MP.

J Med Chem. 2015 Mar 26;58(6):2821-33. doi: 10.1021/acs.jmedchem.5b00043. Epub 2015 Mar 6.

PMID:
25728019
5.

Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life.

Baz R, Lin HM, Hui AM, Harvey RD, Colson K, Gallop K, Swinburn P, Laubach J, Berg D, Richardson P.

Support Care Cancer. 2015 Feb 24. [Epub ahead of print]

PMID:
25708126
6.

Early or delayed transplantation for multiple myeloma in the era of novel therapy: does one size fit all?

Richardson PG, Laubach JP, Munshi NC, Anderson KC.

Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):255-61. doi: 10.1182/asheducation-2014.1.255. Epub 2014 Nov 18.

PMID:
25696864
7.

Management of Relapsed Multiple Myeloma after Autologous Stem Cell Transplant.

Holstein SA, Richardson PG, Laubach JP, McCarthy PL.

Biol Blood Marrow Transplant. 2015 Jan 31. pii: S1083-8791(14)01470-0. doi: 10.1016/j.bbmt.2014.12.026. [Epub ahead of print] Review.

PMID:
25652690
8.

Phospholipid transfer protein plays a major role in the initiation of apolipoprotein B-containing lipoprotein assembly in mouse primary hepatocytes.

Manchekar M, Liu Y, Sun Z, Richardson PE, Dashti N.

J Biol Chem. 2015 Jan 31. pii: jbc.M114.602748. [Epub ahead of print]

9.

Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells.

Ray A, Das DS, Song Y, Richardson P, Munshi NC, Chauhan D, Anderson KC.

Leukemia. 2015 Jan 30. doi: 10.1038/leu.2015.11. [Epub ahead of print] No abstract available.

PMID:
25634684
10.

Geriatric assessment predicts survival and toxicities in elderly myeloma: an International Myeloma Working Group report.

Palumbo A, Bringhen S, Mateos MV, Larocca A, Facon T, Kumar SK, Offidani M, McCarthy P, Evangelista A, Lonial S, Zweegman S, Musto P, Terpos E, Belch A, Hajek R, Ludwig H, Stewart AK, Moreau P, Anderson K, Einsele H, Durie BG, Dimopoulos MA, Landgren O, San Miguel JF, Richardson P, Sonneveld P, Rajkumar SV.

Blood. 2015 Jan 27. pii: blood-2014-12-615187. [Epub ahead of print]

PMID:
25628469
11.

Complete Genome Sequence of Anaeromyxobacter sp. Fw109-5, an Anaerobic, Metal-Reducing Bacterium Isolated from a Contaminated Subsurface Environment.

Hwang C, Copeland A, Lucas S, Lapidus A, Barry K, Glavina Del Rio T, Dalin E, Tice H, Pitluck S, Sims D, Brettin T, Bruce DC, Detter JC, Han CS, Schmutz J, Larimer FW, Land ML, Hauser LJ, Kyrpides N, Lykidis A, Richardson P, Belieav A, Sanford RA, Löeffler FE, Fields MW.

Genome Announc. 2015 Jan 22;3(1). pii: e01449-14. doi: 10.1128/genomeA.01449-14.

12.

Use of Boosted Protease Inhibitors Reduces Kaposi Sarcoma Incidence Among Male Veterans With HIV Infection.

Kowalkowski MA, Kramer JR, Richardson PR, Suteria I, Chiao EY.

Clin Infect Dis. 2015 Jan 13. pii: civ012. [Epub ahead of print]

PMID:
25586682
13.

Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine-Naloxone: HIV Prevention Trials Network 058.

Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN; HPTN 058 Protocol Team.

J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):554-61. doi: 10.1097/QAI.0000000000000510.

PMID:
25564105
14.

The Case of the cannabis conundrum.

Richardson P.

ONS Connect. 2014 Dec;29(4):11. No abstract available.

PMID:
25563044
15.

Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib-melphalan-prednisone in the phase III VISTA study.

Mateos MV, Richardson PG, Dimopoulos MA, Palumbo A, Anderson KC, Shi H, Elliott J, Dow E, van de Velde H, Niculescu L, San Miguel JF.

Am J Hematol. 2015 Apr;90(4):314-9. doi: 10.1002/ajh.23933. Epub 2015 Feb 27.

PMID:
25557740
16.

Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.

Piwowar-Manning E, Fogel JM, Richardson P, Wolf S, Clarke W, Marzinke MA, Fiamma A, Donnell D, Kulich M, Mbwambo JK, Richter L, Gray G, Sweat M, Coates TJ, Eshleman SH.

J Clin Virol. 2015 Jan;62:75-9. doi: 10.1016/j.jcv.2014.11.023. Epub 2014 Nov 27.

PMID:
25542477
17.

Divalent ytterbium complexes with crown and heterocrown ethers.

Bartlett PN, Champion MJ, Light ME, Levason W, Reid G, Richardson PW.

Dalton Trans. 2015 Feb 21;44(7):2953-5. doi: 10.1039/c4dt03462g.

PMID:
25492516
18.

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study.

Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Di Bacco A, Estevam J, Gupta N, Hui AM, Rajkumar V, Richardson PG.

Lancet Oncol. 2014 Dec;15(13):1503-12. doi: 10.1016/S1470-2045(14)71125-8. Epub 2014 Nov 14.

PMID:
25456369
19.

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

Rajkumar SV, Dimopoulos MA, Palumbo A, Blade J, Merlini G, Mateos MV, Kumar S, Hillengass J, Kastritis E, Richardson P, Landgren O, Paiva B, Dispenzieri A, Weiss B, LeLeu X, Zweegman S, Lonial S, Rosinol L, Zamagni E, Jagannath S, Sezer O, Kristinsson SY, Caers J, Usmani SZ, Lahuerta JJ, Johnsen HE, Beksac M, Cavo M, Goldschmidt H, Terpos E, Kyle RA, Anderson KC, Durie BG, Miguel JF.

Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26. Review.

PMID:
25439696
20.

Current treatment landscape for relapsed and/or refractory multiple myeloma.

Dimopoulos MA, Richardson PG, Moreau P, Anderson KC.

Nat Rev Clin Oncol. 2015 Jan;12(1):42-54. doi: 10.1038/nrclinonc.2014.200. Epub 2014 Nov 25.

PMID:
25421279
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk